NCT03414658 2025-07-02The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast CancerDana-Farber Cancer InstitutePhase 2 Active not recruiting100 enrolled 15 charts
NCT03364348 2022-10-194-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast CancerStanford UniversityPhase 1 Completed18 enrolled 17 charts